Publicacions
-
Evans DGR, Salvador-Hernandez H, Chang VY, Erez A, Voss SD, Druker H, Scott HS and Tabori U.
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
CLINICAL CANCER RESEARCH . 23(12): 54-61. Nº de cites: 71
-
Evans DGR, Salvador-Hernandez H, Chang VY, Erez A, Voss SD, Schneider KW, Scott HS, Plon SE and Tabori U.
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
CLINICAL CANCER RESEARCH . 23(12): 46-53. Nº de cites: 119
-
Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
CANCER LETTERS . 380(1): 10-19. Nº de cites: 28
-
Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.
Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)
CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de cites: 14
-
Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent-Genestar J, Guimaraens L, Prat-Bartomeu J and Mora J.
Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study
ACTA OPHTHALMOLOGICA . 92(3): 209-215. Nº de cites: 27
-
Mora J, de Torres C, Parareda A, Torner-Rubies F, Galván P, Rodriguez E, Cardesa-Salzmann TM, Salvador-Hernandez H, Suñol M, Huguet R and Cruz-Martínez O.
Treatment of Ewing Sarcoma Family of Tumors With a Modified P6 Protocol in Children and Adolescents
PEDIATRIC BLOOD & CANCER . 57(1): 69-75. Nº de cites: 13
